Dr. Kathryn Colby: Current perspectives on Fuchs’ dystrophy
Kathryn A. Colby, MD, PhD, discusses Fuchs’ dystrophy symptoms and treatment options as well as the underlying concept of Descemet stripping only surgery and her role in pioneering this technique.
Kathryn A. Colby, MD, PhD, Chair of the Department of Ophthalmology at NYU Langone Health, discusses Fuchs’ dystrophy symptoms and treatment options as well as the underlying concept of Descemet stripping only (DSO) surgery and her role in pioneering this technique with Sheryl Stevenson, Ophthalmology Times®' Group Editorial Director. Dr. Colby also explains who are the best patient candidates, and outlines an interesting patient case and outcomes.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Articles
- The European Commission grants marketing authorization for EYLUXVI
September 23rd 2025
- Luxa Biotechnology announces clinical trial results for treatment of AMD
September 22nd 2025